Global Small
Animal Imaging (In-Vivo) market is expected to reach USD
2.7 billion by 2022, according to a new study by Grand View Research, Inc.
Growing number of medical conditions requiring accurate research for
development of treatment options is expected to enhance demand for small animal
imaging (in-Vivo) over the forecast period. Importance of these devices in
applications such as epigenetic research studies, drug receptor targeting, and
defining mechanism of action is estimated to provide potential growth platform for
this industry. The major factors driving the growth of small animal imaging
(in-vivo) market are growing usage of multi-functional pre-clinical imaging,
rising investments of CROs in pre-clinical studies, increasing number of
pharmaceutical and research organizations and technical innovations such as
high-resolution MRI with other modalities.
Browse full research report on Global Small Animal Imaging Market: https://www.grandviewresearch.com/industry-analysis/small-animal-imaging-in-vivo-market
Further
key findings from the study suggest:
- Optical imaging dominated the technology segment in 2014 in terms
of revenue share of over 45%. Advantages associated with this technology
such as easy and rapid operations and relatively lower costs compared to
other devices are the factors attributing for its high share.
- Micro-MRI technology is expected to be the fastest growing, and is
expected to grow at a lucrative CAGR of over 12.0% by 2022. Micro-MRI has
wide applications during functional and anatomical analysis in developing
mouse neonates and embryos.
- In term of applications, monitoring treatment response,
bio-distribution, cancer cell detection, biomarkers, longitudinal studies
and epigenetic studies are segments studied. In 2014, Bio-distribution and
monitoring the treatment response dominated the overall market in terms of
revenue share of over 33% and 25% respectively.
- The cancer cell detection segment is expected to show prominent
growth rate owing to the rising global prevalence of cancer, and
increasing government initiatives pertaining to cancer diagnostics
research. Cancer cell detection application is expected to generate
revenue of over USD 700 million by 2022, at a CAGR of over 12% from 2015
to 2022.
- North America dominated in terms of revenue in 2014 at 36.1% in
2014. Favorable platform for R&D pertaining to technological
advancements, vast pre-clinical research, established healthcare
infrastructure, and rising demand for rapid and advanced methods are the
key factors attributing for the highest revenue generation in this region.
European market held the second position owing to the large number of
pharmaceutical and clinical research organizations and diagnostic device
manufacturers.
- Asia Pacific regional market is expected to register significant
growth over the forecast period with CAGR of over 11% owing to emerging
economies, growing base of target population, and growing clinical
research activities. Additionally, rising acceptance level for advanced
medical devices is expected to provide potential growth platform for key
players of this market.
- The key players in this industry include Thermo Fisher Scientific,
Inc. Siemens AG, Mediso Medical Imaging Systems, Life Technologies
Corporation, Promega Corporation, Miltenyi Biotech GmbH, Bruker
Corporation, FujiFilm Holding Corporation, PerkinElmer Inc. and Aspect
Imaging Ltd. Companies are developing novel products to sustain their
market positions. For instance, Bruker Corporation has launched SKYSCAN
1176, In-vivo micro-CT, and Wrist MRI Machine from Aspect for effortless
imaging.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/medical-devices
Grand
View Research has segmented the global small animal imaging (In-Vivo)
market on the basis of medium and region:
Global
Small Animal Imaging (In-Vivo) Technology Outlook (Revenue, USD Million, 2012 -
2022)
- Micro-magnetic
resonance imaging
- Optical
imaging
- Nuclear
imaging
- Other imaging
modalities
Global
Small Animal Imaging (In-Vivo) Application Outlook (Revenue, USD Million, 2012
- 2022)
- Monitoring
treatment responseCancer cell detection
- Bio-distribution
- Biomarkers
- Longitudinal
studies
- Epigenetics
Small
Animal Imaging (In-Vivo) Regional Outlook (Revenue, USD Million, 2012 - 2022)
- North America
- Europe
- Asia Pacific
- RoW
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment